Thomas Iftner
- Epidemiology top 0.1%
- Cervical Cancer and HPV Research 148
- Hepatitis B Virus Studies 40
- Microbiology top 0.2%
- Reproductive tract infections research 22
- Oncology top 1%
- Cancer-related Molecular Pathways 11
- Viral-associated cancers and disorders 11
- Obstetrics and Gynecology top 1%
- Surgery top 1%
- Genital Health and Disease 56
-
- Molecular Biology Techniques and Applications 29
-
- Virus-based gene therapy research 27
- Co-authors
- Susanne K. KjærChristian MunkFrank StubenrauchKirsten FrederiksenKarl Ulrich PetryJack CuzickPhilippe BirembautAnne Szarewski
- Cited by
- EpidemiologyMicrobiologyOncology
- Journals
- Journal of Virology (29 papers)International Journal of Cancer (13 papers)Virology (12 papers)
- Partner nations
- GermanyDenmarkUnited States
In The Last Decade
Thomas Iftner
193 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Epidemiology 6.7k
- Microbiology 989
- Oncology 2.1k
- Obstetrics and Gynecology 524
- Surgery 2.5k
Countries citing papers authored by Thomas Iftner
This map shows the geographic impact of Thomas Iftner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Iftner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Iftner more than expected).
Fields of papers citing papers by Thomas Iftner
This network shows the impact of papers produced by Thomas Iftner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Iftner. The network helps show where Thomas Iftner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Iftner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 8 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 13 | |
| 13 | 2020 | 20 | |
| 14 | 2019 | 7 | |
| 15 | 2011 | 58 | |
| 16 | 2010 | 68 | |
| 17 | 2008 | 67 | |
| 18 | 2007 | 279 | |
| 19 | 2006 | 136 | |
| 20 | The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. | 2003 | 164 |
About Thomas Iftner
Thomas Iftner is a scholar working on Epidemiology, Microbiology and Oncology, having authored 197 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (148 papers), Genital Health and Disease (56 papers), Hepatitis B Virus Studies (40 papers), Molecular Biology Techniques and Applications (29 papers), Virus-based gene therapy research (27 papers), Reproductive tract infections research (22 papers), Cancer-related Molecular Pathways (11 papers) and Viral-associated cancers and disorders (11 papers). The work is most often cited by research in Epidemiology (6.7k citations), Microbiology (989 citations) and Oncology (2.1k citations). Thomas Iftner has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Susanne K. Kjær, Christian Munk, Frank Stubenrauch, Kirsten Frederiksen, Karl Ulrich Petry, Jack Cuzick, Philippe Birembaut, Anne Szarewski, Christine Clavel and Juliane Haedicke. Their work appears in journals such as Journal of Virology, International Journal of Cancer, Virology, Journal of Medical Virology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.